echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Feed Industry News > The issue of genetically modified gene remains unresolved. Traders are in a dilemma

    The issue of genetically modified gene remains unresolved. Traders are in a dilemma

    • Last Update: 2001-08-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Introduction: because there are many unknown factors in genetically modified organisms, many traders are afraid to make a single Some businessmen claimed that they had traded two ships of goods last week, one of which was from South America The voyage is in August, and the C & F price is 215 US dollars / ton The other is from the United States with a lift of more than 90 cents per bushel Others believe that China has ordered 12 to 20 U.S new soybeans so far, with a shipment time of October According to their estimates, China will import more than one million tons of soybeans a month on average.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.